Adoptive transfer of CD8+ T cells with edited PDIA3, MGA5, Emp1, or Lag3 improve the survival rate of GBM tumor-bearing mice in both syngeneic and T-cell receptor transgenic models (Ye et al., 2019). This evidence concerns the gene CD8A and neoplasm.